DG Maloney

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

DG Maloney, TM Liles, DK Czerwinski et al. · Blood · 1994 · 753 citations

Medicine, Hematology, Oncology +17

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.

DG Maloney, A.J. Grillo-López, David Bodkin et al. · Journal of Clinical Oncology · 1997 · 638 citations

Pharmacy, Hematology, Pharmacokinetics +17

A clinical trial of anti-idiotype therapy for B cell malignancy

TC Meeker, James N. Lowder, DG Maloney et al. · Blood · 1985 · 424 citations

Life Sciences, Hematology, Immunology +8

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Thomas A. Davis, Christine A. White, A.J. Grillo-López et al. · Journal of Clinical Oncology · 1999 · 289 citations

Pharmacy, Hematology, Pharmacotherapy +13

In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia

RA Miller, DG Maloney, J McKillop et al. · Blood · 1981 · 258 citations · Full text

Pharmacy, Immunology, Oncology +16